ditiocarb has been researched along with Carcinoma, Hepatocellular in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, ZY; Hua, A; Li, J; Li, S; Li, Z; Wang, X; Xiao, C; Xu, C; Yang, X; Zhang, BX; Zhang, Z | 1 |
| Abu-Serie, MM | 1 |
| Bookstein, J; Campbell, TN; Howell, SB; Pfeifle, CE; Wung, WE | 1 |
| Chang, TK; Gonzalez, FJ; Waxman, DJ | 1 |
| Bartsch, H; Frank, N; Lin, JK; Liu, GY | 1 |
| Kang, JH; Wei, YM; Zheng, RL | 1 |
| Fandrey, J; Jelkmann, W; Seydel, FP; Siegers, CP | 1 |
7 other study(ies) available for ditiocarb and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Hydroxyethyl starch stabilized copper-diethyldithiocarbamate nanocrystals for cancer therapy.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Copper; Ditiocarb; Humans; Hydroxyethyl Starch Derivatives; Liver Neoplasms; Nanoparticles; Neoplastic Stem Cells; Starch | 2023 |
Evaluation of the selective toxic effect of the charge switchable diethyldithiocarbamate-loaded nanoparticles between hepatic normal and cancerous cells.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Ditiocarb; Drug Carriers; Hepatocytes; Liver Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Nanoparticles; Neoplastic Stem Cells; Tumor Cells, Cultured | 2018 |
Clinical pharmacokinetics of intraarterial cisplatin in humans.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Cisplatin; Colonic Neoplasms; Ditiocarb; Dose-Response Relationship, Drug; Female; Hepatic Artery; Histiocytoma, Benign Fibrous; Humans; Infusions, Intra-Arterial; Infusions, Parenteral; Kinetics; Ligands; Liver Neoplasms; Male; Melanoma; Middle Aged; Thigh | 1983 |
Evaluation of triacetyloleandomycin, alpha-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes P450.
Topics: Benzoflavones; Carcinoma, Hepatocellular; Cell Line; Cytochrome P-450 Enzyme Inhibitors; Ditiocarb; DNA, Complementary; Humans; Isoenzymes; Kinetics; Liver Neoplasms; Recombinant Proteins; Troleandomycin; Tumor Cells, Cultured | 1994 |
Induction of apoptosis by thiuramdisulfides, the reactive metabolites of dithiocarbamates, through coordinative modulation of NFkappaB, c-fos/c-jun, and p53 proteins.
Topics: Alcohol Deterrents; Antineoplastic Agents; Antioxidants; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p27; Disulfiram; Ditiocarb; G1 Phase; Humans; Microtubule-Associated Proteins; NF-kappa B; Oxidation-Reduction; Proline; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Thiocarbamates; Transcription Factor AP-1; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 1998 |
Effects of diethyldithiocarbamate on proliferation, redifferention, and apoptosis in human hepatoma cells.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Carcinoma, Hepatocellular; Cell Division; Ditiocarb; Humans; Liver Neoplasms; Reactive Oxygen Species; Tumor Cells, Cultured | 2001 |
Role of cytochrome P450 in the control of the production of erythropoietin.
Topics: Carcinoma, Hepatocellular; Cobalt; Cysteamine; Cytochrome P-450 Enzyme System; Ditiocarb; Erythropoietin; Humans; Liver Neoplasms; Methylcholanthrene; Metyrapone; Microsomes; Oxygen; Phenobarbital; Thyroxine; Triiodothyronine; Tumor Cells, Cultured | 1990 |